Johnson JA - Search Results

1

Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements.

Aquilante CL, Langaee TY, Lopez LM, Yarandi HN, Tromberg JS, Mohuczy D, Gaston KL, Waddell CD, Chirico MJ, Johnson JA. Aquilante CL, et al. Among authors: johnson ja. Clin Pharmacol Ther. 2006 Apr;79(4):291-302. doi: 10.1016/j.clpt.2005.11.011. Epub 2006 Feb 28. Clin Pharmacol Ther. 2006. PMID: 16580898 Clinical Trial.

2

Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.

Lima JJ, Thomason DB, Mohamed MH, Eberle LV, Self TH, Johnson JA. Lima JJ, et al. Among authors: johnson ja. Clin Pharmacol Ther. 1999 May;65(5):519-25. doi: 10.1016/S0009-9236(99)70071-8. Clin Pharmacol Ther. 1999. PMID: 10340917

3

Predictability of the effects of race or ethnicity on pharmacokinetics of drugs.

Johnson JA. Johnson JA. Int J Clin Pharmacol Ther. 2000 Feb;38(2):53-60. doi: 10.5414/cpp38053. Int J Clin Pharmacol Ther. 2000. PMID: 10706191 Review.

4

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.

Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF. Johnson JA, et al. Clin Pharmacol Ther. 2003 Jul;74(1):44-52. doi: 10.1016/S0009-9236(03)00068-7. Clin Pharmacol Ther. 2003. PMID: 12844134

5

Comparison of cytochrome P450 2C9 genotyping methods and implications for the clinical laboratory.

Aquilante CL, Lobmeyer MT, Langaee TY, Johnson JA. Aquilante CL, et al. Among authors: johnson ja. Pharmacotherapy. 2004 Jun;24(6):720-6. doi: 10.1592/phco.24.8.720.36074. Pharmacotherapy. 2004. PMID: 15222661

6

Influence of gender and race on hemodynamic response to dobutamine during dobutamine stress echocardiography.

Aquilante CL, Humma LM, Yarandi HN, Andrisin TE, Lewis JF, Hamilton KK, Johnson JA. Aquilante CL, et al. Among authors: johnson ja. Am J Cardiol. 2004 Aug 15;94(4):535-8. doi: 10.1016/j.amjcard.2004.04.076. Am J Cardiol. 2004. PMID: 15325950

7

Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.

Kim K, Johnson JA, Derendorf H. Kim K, et al. Among authors: johnson ja. J Clin Pharmacol. 2004 Oct;44(10):1083-105. doi: 10.1177/0091270004268128. J Clin Pharmacol. 2004. PMID: 15342610 Review.

8

Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.

Zineh I, Beitelshees AL, Gaedigk A, Walker JR, Pauly DF, Eberst K, Leeder JS, Phillips MS, Gelfand CA, Johnson JA. Zineh I, et al. Among authors: johnson ja. Clin Pharmacol Ther. 2004 Dec;76(6):536-44. doi: 10.1016/j.clpt.2004.08.020. Clin Pharmacol Ther. 2004. PMID: 15592325

9

beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.

Terra SG, Pauly DF, Lee CR, Patterson JH, Adams KF, Schofield RS, Belgado BS, Hamilton KK, Aranda JM, Hill JA, Yarandi HN, Walker JR, Phillips MS, Gelfand CA, Johnson JA. Terra SG, et al. Among authors: johnson ja. Clin Pharmacol Ther. 2005 Mar;77(3):127-37. doi: 10.1016/j.clpt.2004.10.006. Clin Pharmacol Ther. 2005. PMID: 15735607 Clinical Trial.

10

Sequencing drug response with HapMap.

Lin M, Aquilante C, Johnson JA, Wu R. Lin M, et al. Among authors: johnson ja. Pharmacogenomics J. 2005;5(3):149-56. doi: 10.1038/sj.tpj.6500302. Pharmacogenomics J. 2005. PMID: 15782224

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,773 results

Search Page

Filters